Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.93 USD | -2.05% | -7.69% | +74.19% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.19% | 534M | |
+7.96% | 113B | |
+10.40% | 106B | |
+0.41% | 22.27B | |
-12.02% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.86% | 17.24B | |
+7.08% | 14.29B | |
+36.71% | 12.52B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Wedbush Trims Y-mAbs Therapeutics' Price Target to $12 From $13, Keeps Outperform Rating